Actively Recruiting

Age: 18Years +
All Genders
NCT05385315

Towards the Validation of a New Blood Biomarker for the Early Diagnosis of Parkinson's Disease

Led by University Hospital, Grenoble · Updated on 2024-12-11

70

Participants Needed

1

Research Sites

167 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Grenoble

Lead Sponsor

G

Grenoble Institut des Neurosciences

Collaborating Sponsor

AI-Summary

What this Trial Is About

The investigators have recently discovered a metabolic biomarker which predicts Parkinson's disease (PD) at the early stages in patients and in animal models. The aim of BIOPARK is to investigate how the biomarker evolves in advanced PD stage, when diagnosis confirmation is higher, an in de novo PD patients who come from a different geographical area than those of the publication (since it is known that the metabolome is largely influenced by lifestyle). They will also evaluate if the biomarker is able to distinguish patients with a parkinsonian syndrome often confused with parkinson's disease, i.e. Multiple System Atrophy (MSA).

CONDITIONS

Official Title

Towards the Validation of a New Blood Biomarker for the Early Diagnosis of Parkinson's Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with de novo Parkinson's disease, without dopaminergic treatment
  • Patients with advanced Parkinson's disease (> 5 years) with dopaminergic treatment
  • Patients with multiple system atrophy
Not Eligible

You will not qualify if you...

  • Patients with deep brain stimulation
  • Patients with other neurodegenerative diseases
  • Patients protected by French law (pregnant or lactating women, prisoners, etc.)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU Grenoble Alpes

Grenoble, France, 38043

Actively Recruiting

Loading map...

Research Team

F

Florence Fauvelle, PhD

CONTACT

A

Andrea Kistner, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here